花房集團(03611.HK)料最快本月底刊發2022年年度業績 續停牌
花房集團(03611.HK)表示,刊發2022年經審核年度業績及2023年中期業績以及寄發2022年年報及2023年中期報告仍有待完成。中審眾環(香港)會計師事務所有限公司已獲委任為公司新任核數師,自2023年8月17日起生效,任期直至公司下一屆股東週年大會結束為止。
公司指,由於核數師需要額外時間落實2022年經審核年度業績的若干資料,料尚未公佈財務業績的核數預計將於1月31日前完成。
公司股份已自2023年4月3日上午九時正起於聯交所暫停買賣,直至刊發2022年經審核年度業績,並將繼續暫停買賣以待達成復牌指引及其任何補充或修訂。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.